Retatrutide was found to inhibit the HBP, thereby preventing YAP O-GlcNAcylation and promoting its degradation
Peptide Vials (BPC-157, 5 mg each): 8 weeks 6 vials (25.2 mg used) 12 weeks 9 vials (42 mg used) 16 weeks 12 vials (58.8 mg used) Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
Foundational Discovery Selective Senolytic Elimination in Aged Mice (Cell, 2017 Baar et al.) FOXO4-DRI Restores Fitness, Fur Density, Renal and Liver Function in Aged Mice The foundational study introducing FOXO4-DRI as a senolytic peptide was published in Cell by Baar and colleagues in 2017
Its a field where progress can feel painstakingly slow, and the search for compounds that can reliably support the body's natural healing mechanisms is relentless
Over time, the term BPC-157 has appeared across research discussions and consumer products in ways that arent always clearly differentiated, including references to laboratory research, injectable use in medical or research contexts, and dietary supplements
